ALT - Altimmune, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.25
DETAILS
HIGH:
$10.00
LOW:
$2.50
MEDIAN:
$6.25
CONSENSUS:
$6.25
UPSIDE:
100.96%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 6,700,000 | $20.4M | 0.1% | +6,700,000 | NEW |
| Wood | 486,884 | $1.5M | 0.0% | -178,405 | DECREASED |
| Laffont | 239,280 | $727,411 | 0.0% | -- | UNCHANGED |
| Cooperman | 201,638 | $612,979 | 0.0% | -525,363 | DECREASED |
| Greenblatt | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-13 | Durso Jerome Benedict | director, officer: President and CEO | BUY | 15,000 | $2.95 | $44K |
| 2026-07-31 | WEAVER GREGORY L | officer: Chief Financial Officer | A-Award | 1,753 | $2.41 | $4K |
| 2026-07-31 | Roberts M Scot | officer: Chief Scientific Officer | A-Award | 875 | $2.41 | $2K |
| 2026-05-01 | Jorkasky Diane | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | GILL JOHN | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | Hodges Philip | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | Sohn Catherine A. | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | Lawver Teri L | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | SAYARE MITCHEL | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | Schafer Klaus | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-05-01 | Pisano Wayne | director | A-Award | 48,800 | $2.82 | $138K |
| 2026-04-06 | GILL JOHN | director | BUY | 9,200 | $3.41 | $31K |
| 2026-04-01 | Durso Jerome Benedict | director, officer: President and CEO | BUY | 15,000 | $3.14 | $47K |
| 2026-04-01 | WEAVER GREGORY L | officer: Chief Financial Officer | BUY | 10,000 | $3.15 | $31K |
| 2026-03-06 | WEAVER GREGORY L | officer: Chief Financial Officer | BUY | 5,000 | $3.54 | $18K |
| 2026-03-06 | Durso Jerome Benedict | director, officer: President and CEO | BUY | 20,000 | $3.54 | $71K |
| 2026-02-26 | WEAVER GREGORY L | officer: Chief Financial Officer | A-Award | 111,000 | -- | -- |
| 2026-02-26 | WEAVER GREGORY L | officer: Chief Financial Officer | A-Award | 259,000 | $4.46 | $1.2M |
| 2026-02-26 | Roberts M Scot | officer: Chief Scientific Officer | A-Award | 95,430 | -- | -- |
| 2026-02-26 | Roberts M Scot | officer: Chief Scientific Officer | A-Award | 222,670 | $4.46 | $993K |
| 2026-01-31 | Roberts M Scot | officer: Chief Scientific Officer | A-Award | 5,567 | $3.07 | $17K |
| 2026-02-02 | Roberts M Scot | officer: Chief Scientific Officer | F-InKind | 2,329 | $5.55 | $13K |
| 2026-01-30 | Roberts M Scot | officer: Chief Scientific Officer | M-Exempt | 9,275 | -- | -- |
| 2026-02-02 | Roberts M Scot | officer: Chief Scientific Officer | M-Exempt | 7,775 | -- | -- |
| 2026-01-30 | Roberts M Scot | officer: Chief Scientific Officer | F-InKind | 2,859 | $5.60 | $16K |